{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03631589",
      "OrgStudyIdInfo": {
        "OrgStudyId": "MSC-SCT-01"
      },
      "Organization": {
        "OrgFullName": "Fujian Medical University",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "MSC for Severe aGVHD",
      "OfficialTitle": "Treatment of Steroid-resistant Severe Acute Graft-versus-host Disease With Mesenchymal Stem Cells"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2018",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "December 1, 2017",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 1, 2019",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 1, 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "August 13, 2018",
      "StudyFirstSubmitQCDate": "August 13, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "August 15, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "August 13, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "August 15, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Jianda Hu",
        "ResponsiblePartyInvestigatorTitle": "Director of the department of Hematology",
        "ResponsiblePartyInvestigatorAffiliation": "Fujian Medical University"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Fujian Medical University",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Steroid-resistant acute graft-versus-host disease (aGVHD) is one of the most severe complications in the setting of allogeneic hematopoietic stem cell transplantation (HSCT), which cannot be significant benefit from the second-line therapies.The mesenchymal stem cells (MSCs) possess extensive immunomodulatory properties and are very promising to rescue the refractory aGVHD.This study aims to assess the efficacy and safety of MSCs for the treatment of the refractory aGVHD."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Steroid-resistant Severe aGVHD"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2",
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "50",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "MSCs treated",
            "ArmGroupType": "Experimental",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: MSCs"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "MSCs",
            "InterventionDescription": "mesenchymal stem cells therapy",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "MSCs treated"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "complete and partial response rate",
            "PrimaryOutcomeTimeFrame": "1 year"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Adverse events that are related to treatment",
            "SecondaryOutcomeTimeFrame": "1 year"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nSigned written informed consent\nAged <65 years\nPatients with steroid-resistant severe aGVHD\nCardiac: Left ventricular ejection fraction ≥ 50%\nAdequate renal and hepatic function\nPerformance status: Karnofsky ≥ 70%\n\nExclusion Criteria:\n\nPregnant or lactating females.\nAny co-morbidity precluding the administration of MSCs.",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MaximumAge": "65 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "Jianda Hu, Prof.M.D.Ph.D",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "86-13959169016",
            "CentralContactEMail": "drjiandahu@163.com"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Fujian Medical University Union Hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Fuzhou",
            "LocationState": "Fujian",
            "LocationZip": "350001",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "Jianda Hu, Prof.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "86-13959169016",
                  "LocationContactEMail": "drjiandahu@163.com"
                },
                {
                  "LocationContactName": "Ting Yang, Prof.",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "86-13950210357",
                  "LocationContactEMail": "yang.hopeting@gmail.com"
                },
                {
                  "LocationContactName": "Jianda Hu, Prof.",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8341",
            "ConditionBrowseLeafName": "Graft vs Host Disease",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T2832",
            "ConditionBrowseLeafName": "Homologous Wasting Disease",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "T170",
            "ConditionBrowseLeafName": "Acute Graft Versus Host Disease",
            "ConditionBrowseLeafAsFound": "aGVHD",
            "ConditionBrowseLeafRelevance": "high"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC20",
            "ConditionBrowseBranchName": "Immune System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "Rare",
            "ConditionBrowseBranchName": "Rare Diseases"
          }
        ]
      }
    }
  }
}